Home › Funds › Twin Lakes Capital Management, LLC › ATHE

Twin Lakes Capital Management, LLC position in ATHE

ALTERITY THERAPEUTICS LTD · Health Care

Twin Lakes Capital Management, LLC reported holding 139,258 shares of ATHE (ALTERITY THERAPEUTICS LTD) in its Q2 2026 13F filing — a position valued at US$748K, representing 0.29% of its reported portfolio and ranking #47 among its reported holdings. Twin Lakes Capital Management, LLC has disclosed ATHE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)139.26K sh
Reported value held$747.82K
Portfolio Weight0.29%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Twin Lakes Capital Management, LLC's ATHE position evolved

Twin Lakes Capital Management, LLC first disclosed a stake in ATHE in Q3 2023 at 5,925 shares (US$15K). The position peaked in Q2 2026 at 139,258 shares, worth US$748K. Across 12 filings, Twin Lakes Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 139,258 shares valued at US$748K. Notable position changes include a 2250% increase in Q3 2025 (shares fell 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 5.92K $14.69K New
Q4 2023 5.92K $14.75K Hold
Q1 2024 5.92K $12.27K Hold
Q2 2024 5.92K $10.72K Hold
Q3 2024 5.92K $7.78K Hold
Q4 2024 5.92K $19.61K Hold
Q1 2025 5.92K $20.44K Hold
Q2 2025 5.92K $24.22K Hold
Q3 2025 139.26K $523.61K Add
Q4 2025 139.26K $428.92K Hold
Q1 2026 139.26K $484.62K Hold
Q2 2026 139.26K $747.82K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ATHE and 13F data

ATHE (ALTERITY THERAPEUTICS LTD) is a Health Care company. 20 other funds we track also report a position in ATHE. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ATHE

No other tracked fund reports a position in ATHE.

All ATHE fund holders →

FAQ

How long has Twin Lakes Capital Management, LLC held ATHE?

Twin Lakes Capital Management, LLC has disclosed ATHE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Twin Lakes Capital Management, LLC's current position in ATHE?

As of Q2 2026, Twin Lakes Capital Management, LLC holds 139.26K shares of ATHE (ALTERITY THERAPEUTICS LTD), valued at $747.82K, representing 0.29% of its reported portfolio and ranking #47.

Has Twin Lakes Capital Management, LLC been buying or selling ATHE?

In the latest 13F filing (Q2 2026), Twin Lakes Capital Management, LLC held unchanged its position in ATHE. The position peaked in Q2 2026 at 139.26K shares.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.